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Abstract
Background: Cell migration plays an important role in many physiological and pathological processes, including
immune cell chemotaxis and cancer metastasis. It is a coordinated process that involves dynamic changes in the
actin cytoskeleton and its interplay with focal adhesions. At the leading edge of a migrating cell, it is the re-
arrangement of actin and its attachment to focal adhesions that generates the driving force necessary for
movement. However, the mechanisms involved in the attachment of actin filaments to focal adhesions are still not
fully understood.
Results: Signaling by the FAK-Src complex plays a crucial role in regulating the formation of protein complexes at
focal adhesions to which the actin filaments are attached. Cortactin, an F-actin associated protein and a substrate
of Src kinase, was found to interact with FAK through its SH3 domain and the C-terminal proline-rich regions of
FAK. We found that the autophosphorylation of Tyr
397 in FAK, which is necessary for FAK activation, was not
required for the interaction with cortactin, but was essential for the tyrosine phosphorylation of the associated
cortactin. At focal adhesions, cortactin was phosphorylated at tyrosine residues known to be phosphorylated by
Src. The tyrosine phosphorylation of cortactin and its ability to associate with the actin cytoskeleton were required
in tandem for the regulation of cell motility. Cell motility could be inhibited by truncating the N-terminal F-actin
binding domains of cortactin or by blocking tyrosine phosphorylation (Y421/466/475/482F mutation). In addition,
the mutant cortactin phosphorylation mimic (Y421/466/475/482E) had a reduced ability to interact with FAK and
promoted cell motility. The promotion of cell motility by the cortactin phosphorylation mimic could also be
inhibited by truncating its N-terminal F-actin binding domains.
Conclusions: Our results suggest that cortactin acts as a bridging molecule between actin filaments and focal
adhesions. The cortactin N-terminus associates with F-actin, while its C-terminus interacts with focal adhesions. The
tyrosine phosphorylation of cortactin by the FAK-Src complex modulates its interaction with FAK and increases its
turnover at focal adhesions to promote cell motility.
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Background
Src is a non-receptor cytoplasmic tyrosine kinase acti-
vated by integrins and receptor tyrosine kinases [1]. In
normal cells, Src is involved in a vast range of physiolo-
gical functions, including cell proliferation, cytoskeletal
regulation, cell shape control, cell-matrix adhesion
dynamics and motility [2,3]. In many types of human
cancer, Src is overexpressed or hyperactivated [4,5]. The
prominent role of Src in regulating cytoskeletal
dynamics and cell motility makes the study of Src indis-
pensable in understanding cancer cell migration and
invasion.
Initially identified as a tyrosine-phosphorylated protein
in v-Src infected chicken embryo fibroblasts [6], cortac-
tin is a direct substrate of cellular Src kinase [7]. It is
phosphorylated by Src at three tyrosine residues (Tyr
421,
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any medium, provided the original work is properly cited.466, 482 of murine cortactin) in vitro [8]. The phosphory-
lation of Tyr
475 was identified by a mass spectrometry
study [9]. These tyrosine phosphorylation sites reside in
the proline-rich region, which is the least conserved
domain in cortactin from different species [10].
Many studies have suggested that cortactin and its tyr-
osine phosphorylation regulate lamellipodial protrusion,
cell spreading, intercellular adhesion and cell motility
[11-13]. Src-catalyzed cortactin tyrosine phosphorylation
is involved in integrin-mediated cell adhesion and
spreading [14]. Cortactin knockdown in murine fibro-
blasts impairs both random and directional cell migra-
tion [15]. The expression of cortactin mutated at Src
phosphorylation sites (Y421/466/482F) decreases cell
motility in ECV304 endothelial cells [8]. The impaired
cell motility in cortactin knockdown gastric cancer cell
lines, with a low cortactin phosphorylation level, can be
rescued by the ectopic expression of wild-type cortactin,
but not by the mutant cortactin (Y421/466/482F) [16].
Early studies revealed that cortactin colocalizes with F-
actin in the cortical structures of adherent cells [7,17]. It
associates with the F-actin cytoskeleton through the F-
actin binding tandem cortactin repeats and the N-term-
inal acidic domain that interacts with the actin-related
protein (Arp) 2/3 complex for dendritic actin nucleation
[10,18,19]. At the cell periphery, the F-actin cytoskeleton
forms a highly organized meshwork that controls mem-
brane protrusion and regulates cell motility [20,21].
During cell migration, the propelling force is generated
by membrane protrusions and by membrane-matrix
adhesions, called focal adhesions, at which transmem-
brane integrins link the extracellular matrix to the intra-
cellular actin cytoskeleton [22].
In contrast to the cortactin that colocalizes with F-
actin at cortical regions, tyrosine phosphorylated cor-
tactin (pTyr
421, 466, 482) is almost exclusively localized
at focal adhesions [16,23]. It is colocalized with paxillin
and vinculin at the ends of F-actin stress fibers [16,23].
At focal adhesions, the clustered integrins recruit FAK
and facilitate its activation, forming an active FAK-Src
complex that initiates many intracellular signaling
events [24-27]. The autophosphorylation of FAK at
Tyr
397 creates a high affinity binding site for the Src-
homology 2 domain of Src kinase [28]. The binding of
Src to FAK leads to the formation of an active FAK-
Src complex in which the active Src kinase trans-phos-
phorylates FAK at Tyr
576, 577 for maximal FAK cataly-
tic activity [29].
FAK recruits adaptor proteins and signaling molecules
into focal adhesions, at which many are phosphorylated
by the FAK-Src complex. The N-terminal FERM domain
binds to growth factor receptors, the C-terminal FAT
domain interacts with talin and paxillin, and the pro-
line-rich regions recruit Src-homology 3 (SH3) domain-
containing proteins, such as p130Cas, GRAF and
ASAP1 [26,30].
In this study, we report that cortactin interacted with
FAK at focal adhesions at which it is phosphorylated by
the FAK-Src complex. Cortactin helps mediate the asso-
ciation of F-actin with focal adhesions. Its N-terminus
interacts with F-actin, and its C-terminus associates
with FAK. The tyrosine phosphorylation of cortactin by
the FAK-Src complex reduces its interaction with FAK,
most likely to increase its turnover at focal adhesions to
promote cell motility.
Results
Colocalization of tyrosine phosphorylated cortactin and
the active FAK-Src complex at focal adhesions
Cortactin, Src and actin are colocalized at the leading
edge of lamellipodia in several types of cells, including
COS7 cells (Figure 1A) [11]. In contrast, the tyrosine
phosphorylated cortactin (at Src kinase site Tyr
421)
clustered into dots, which were localized to focal adhe-
sions marked by paxillin (Figure 1D) [23]. The phos-
phorylated cortactin at focal adhesions was
phosphorylated at all three Src kinase sites (Tyr
421, 466,
482) (Figure 2A) (the information about these antibo-
dies is provided in the Methods section). It could be
dephosphorylated by alkaline phosphatase. No signal
was detected by antibodies against phosphorylated cor-
tactin in alkaline phosphatase-treated cells (Figure 2A).
In addition, the active Src kinase (phosphorylated at
Tyr
418) was also colocalized with focal adhesions (Fig-
ure 1D). The kinase and its product of phosphorylated
cortactin were colocalized at focal adhesions to which
actin stress fibers were attached.
Cortactin and its phosphorylated forms had very dif-
ferent cellular distribution pattern in cell, implicating
additional functions for phosphorylated cortactin (Figure
1E). At the lamellipodial leading edge, cortactin and its
tyrosine phosphorylated forms had a different localiza-
tion (Figure 1A and 1B). Cortactin traced the lamellipo-
dial edge. However, phosphorylated cortactin dotted the
edge and was colocalized with paxillin and Tyr
418-phos-
phorylated Src at the newly formed focal contacts (Fig-
ure 1B and 1C). During cell-matrix interactions, the
clustering of integrins forms focal contacts, and then
focal adhesions, at the leading edge of the lamellipodia
[31]. At focal adhesions, Src binds to Tyr
397-phosphory-
lated FAK to form an active FAK-Src complex (Figure
1C and 1D) [26,28]. The colocalization of tyrosine phos-
phorylated cortactin with Tyr
418-phosphorylated Src at
focal adhesions implicates Src in cortactin tyrosine
phosphorylation at focal adhesions (Figure 1D). It was
further supported by the colocalization of phosphory-
lated cortactin with Tyr
397-autophosphorylated FAK
(Figure 2B).
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Page 2 of 15Cortactin interacts with FAK and its tyrosine
phosphorylation reduces the interaction
Results from immunoprecipitation analysis indicated
that cortactin interacts with FAK but not with paxillin
(results not shown). Cortactin was clustered with FAK
at newly formed focal adhesions at the leading lamelli-
podial edge of migrating cells (Figure 3A). To examine
their interaction at focal adhesions, GFP-tagged
Figure 1 Colocalization of tyrosine phosphorylated cortactin and active Src at focal adhesions. Bar, 10 μm. (A) Colocalization of cortactin,
Src and actin at the lamellipodial edge. COS7 cells were fixed with paraformaldehyde and Triton X-100, and stained with anti-cortactin antibody
(Cttn), anti-Src antibody (Src), phalloidin (pha) and DAPI (DAPI). M, the merged picture; stag., the staggered picture. X2, 2 times enlargement. (B)
The lamellipodial edge stained with an anti-cortactin (Cttn) or an anti-Tyr
421-phosphorylated cortactin (pCttn) antibody. (C) Colocalization of
Tyr
421-phosphorylated cortactin (pCttn) and Tyr
418-phosphorylated Src (pSrc) at focal contacts at the lamellipodial edge. Pax, anti-paxillin antibody
staining. (D) Colocalization of Tyr
421-phosphorylated cortactin and Tyr
418-phosphorylated Src at focal adhesions. (E) The immunofluorescence
staining of Tyr
421 or 466-phosphorylated cortactin. COS7 cells expressing exogenous EGFP-tagged cortactin (GFP-Cttn) were stained with anti-
phosphotyrosine
421 or anti-phosphotyrosine
466 antibody (pCttn
421, pCttn
466).
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Page 3 of 15Figure 2 Colocalization of tyrosine phosphorylated cortactin and FAK at focal adhesions. Bar, 10 μm. (A) Dephosphorylation of Tyr
421, 466
or 482-phosphorylated cortactin by alkaline phosphatase. Fixed COS7 cells were treated with 0.5 unit/μl calf intestinal alkaline phosphatase in 1 ×
TTBS (Tween/Tris-buffered saline, 25 mM Tris-HCl, pH 7.5, 150 mM NaCl, 0.05% Tween and 0.001% thimerosal) for 1 hour at room temperature,
and then immunofluorescence-labeled with anti-FAK antibody (FAK), phalloidin (phalloidin), and with an anti-phosphotyrosine
421, anti-
phosphotyrosine
466 or anti-phosphotyrosine
482 cortactin antibody (pCttn
421, pCttn
466, pCttn
482). Ctrl, without alkaline phosphatase treatment. (B)
Colocalization of Tyr
421-phosphorylated cortactin with FAK at focal adhesions. FAK, anti-FAK antibody staining. pFAK, anti-Tyr
397-phosphorylated
FAK antibody staining.
Wang et al. BMC Cell Biology 2011, 12:49
http://www.biomedcentral.com/1471-2121/12/49
Page 4 of 15cortactin mutants were expressed in COS7 cells, and the
cellular extracts were immunoprecipitated using an anti-
FAK antibody (Figure 4A). As shown in Figure 4C, only
the cortactin C-terminus interacted with FAK. There
was no interaction between the cortactin N-terminal F-
actin binding domains and FAK.
The cortactin C-terminus contains two important
functional domains: the proline-rich region containing
Src kinase phosphorylation sites and the SH3 domain
(7-10). The cortactin SH3 domain participates in the
interaction with FAK. In GST pulldown experiments,
the deletion of the SH3 domain reduced, but did not
completely block, the interaction with FAK (Figure 4E).
Cortactin tyrosine phosphorylation was not required for
the interaction with FAK, but it regulated their interac-
tion. The phosphorylation-incompetent cortactin (Y421/
466/475/482F) bound FAK, similar to wild-type cortac-
tin (Figure 4D). However, the cortactin phosphorylation
mimic (Y421/466/475/482E) exhibited a much weaker
association with FAK (Figure 4D). Thus, both the pro-
line-rich region and the SH3 domain at the cortactin C-
terminus were important for the cortactin-FAK
interaction.
The autophosphorylation of FAK at Tyr
397 is essential
for the binding to Src to form the FAK-Src complex. To
determine if Src in the FAK-Src complex mediates the
interaction between cortactin and FAK, Tyr
397 in FAK
was mutated. Exogenous GFP-tagged FAK was
expressed in COS7 cells and was found to localize to
focal adhesions (Figure 3B). In the GST pull-down
assay, the GFP-tagged FAK and the GFP-tagged FAK
mutant (Y397F) exhibited no difference in their associa-
tion with GST-cortactin (Figure 4F), indicating that the
interaction between cortactin and FAK is not mediated
by Src.
Of the several functional domains in FAK, the cortac-
tin-interaction domain resides in proline-rich regions 2
and 3 (Figure 4B and 4G). By mutating the proline
Figure 3 Cortactin clustering at nascent focal adhesions in migrating cells. (A) Immunofluorescence staining of cortactin and FAK on the
leading edge of migrating HT1080 cells. Bar, 20 μm. The HT1080 cell monolayer was scratched with a rubber policeman. After 2 hours, the cells
were fixed and stained with anti-cortactin antibody, anti-FAK antibody and phalloidin. The arrow indicates the direction of cell migration. The big
arrowheads indicate the edge of lamellipodia, and the small arrowheads indicate focal adhesions. The insert represents the enlarged area. The
images of the anti-cortactin and anti-FAK labeling are merged. (B) The localization of GFP-tagged FAK at focal adhesions. Bar, 20 μm. COS7 cells
were transiently transfected with the GFP-tagged FAK expression vector and cells were fixed and stained with anti-cortactin (Cttn) and anti-
paxillin (Pax) antibodies. GFP-FAK, GFP fluorescence. M, merged picture.
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Page 5 of 15Figure 4 Interaction of cortactin with FAK. (A) Diagram of the various cortactin mutants. Y represents the tyrosine residues at amino acid
positions 421, 466, 475 and 482. F and E indicate Phe and Glu mutations, respectively. NTA, the N-terminal acidic region; Repeats, the cortactin
tandem repeats; H, the helix region; Proline-rich, the proline-rich region; SH3, the Src-homology 3 domain. (B) Diagram of the various FAK
mutants. P712/715A and P876/879A indicate Ala mutations at Pro
712, 715 and Pro
876, 879, respectively. FERM, the N-terminal FERM domain; Kinase,
the central kinase domain; FAT, the C-terminal focal-adhesion targeting domain; FRNK, FAK-related non-kinase region; P, the proline-rich region.
(C) GFP-tagged cortactin mutants expressed in COS7 cells were co-immunoprecipitated with anti-FAK antibody (a-FAK). Input, cell lysates; WB,
western blot; IP, immunoprecipitation; a-GFP, anti-EGFP antibody. (D) The interaction of FAK with the cortactin phosphorylation mimic (Y/E) and
phosphorylation-incompetent (Y/F) cortactin. (E) Interaction of SH3-deleted cortactin with FAK. GST fusion proteins immobilized on glutathione-
beads were used to pull-down GFP-tagged FAK expressed in HEK293 cells. Coomassie, Coomassie blue staining. The arrow-heads indicate GST-
cortactin and GST-SH3-deleted cortactin. The rectangle highlighted the low-exposed GFP-FAK bands. (F) The interaction of cortactin with FAK
mutant (Y397F). GFP-tagged FAK or FAK mutant (Y397F) expressed in HEK293 cells was pulled-down with GST-cortactin. The arrowhead indicates
GST-cortactin. (G) Interaction of cortactin with FAK proline-rich regions. GFP-tagged FAK mutants expressed in HEK293 cells were pulled down
with GST-cortactin. (H) Interaction of cortactin with proline-rich region-mutated FRNK. FRNKm1, P712/715A FRNK; FRNKm2, P786/789A FRNK;
FRNKm1/2, P712/715/786/789A FRNK.
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P712/715A, m2 in proline-rich region 3 P876/879A and
m1/2 P712/715/876/879A), their interaction with cortac-
tin was decreased (Figure 4H). This suggests that the
interaction between cortactin and FAK is mediated by
the C-terminal domains of cortactin and proline-rich
regions 2 and 3 of FAK, and that it is regulated by cor-
tactin tyrosine phosphorylation.
Cell adhesion induced cortactin tyrosine phosphorylation
at focal adhesions
Cell adhesion induces the formation of the FAK-Src
complex, which leads to the phosphorylation of various
FAK-associated proteins [26]. During the adhesion of
suspended HEK293 cells in a fibronectin-coated dish,
FAK autophosphorylation and the phosphorylation of
FAK-associated p130Cas were both increased (Figure
5A). As a FAK associated protein, cortactin was also
phosphorylated on tyrosine residues during this cell
adhesion process (Figure 5B). The co-immunoprecipita-
tion of FAK and its autophosphorylated form from
adherent cells using an anti-cortactin antibody demon-
strates the association of tyrosine phosphorylated cortac-
tin with the FAK-Src complex (Figure 5C).
During the initial stage of cell adhesion and spreading,
FAK, cortactin and actin were all colocalized at the edge
of the membrane (Figure 5D). Cell adhesion induced
FAK clustering and focal adhesion formation. FAK at
focal adhesions was autophosphorylated (Figure 5D and
5E). In these adherent cells, cortactin was still primarily
localized to the cell cortex, and cortactin clustering
could only be observed at newly formed focal contacts
at the leading edge of the lamellipodia (Figure 3A and
5D). However, cortactin was tyrosine phosphorylated at
focal adhesions (Figure 2 and 5E). The tyrosine phos-
phorylation of cortactin might decrease its interaction
with FAK, because the cortactin phosphorylation mimic
(Y421/466/475/482E) exhibited a much weaker associa-
tion with FAK (Figure 4D).
FAK-Src complex is required for cortactin tyrosine
phosphorylation at focal adhesions
To examine the function of the FAK-Src complex in
cortactin tyrosine phosphorylation, FAK was knocked
down by RNA interference in COS7 cells (Figure 5G
and 5H). Cortactin expression was not affected by FAK
knockdown, but cortactin tyrosine phosphorylation was
greatly reduced (Figure 5G). Because focal adhesions
can still form in FAK-deficient cells [32], cortactin tyro-
sine phosphorylation at focal adhesions in FAK knock-
down COS7 cells was analyzed by immunofluorescence
s t a i n i n g .A ss h o w ni nF i g u r e5 H ,c o r t a c t i nt y r o s i n e
phosphorylation was not detected at focal adhesions. In
contrast, cortactin knockdown by RNA interference had
no effect on FAK or its autophosphorylation (Figure 5F).
Thus, these results suggest that at focal adhesions cor-
tactin interacts with FAK, which is required for cortac-
tin tyrosine phosphorylation.
FAK autophosphorylation at Tyr
397 is essential for the
formation of the FAK-Src complex. By mutating Tyr
397 of
FAK into Phe, the formation of the FAK-Src complex at
focal adhesions can be disrupted [26]. In the GFP-tagged
FAK (Y397F) mutant, autophosphorylation at Tyr
397 was
abolished and Src-catalyzed Tyr
576 phosphorylation was
inhibited (Figure 5I). However, the interaction of FAK
with cortactin was not affected by the mutation at Tyr
397
in GST pull-down experiments (Figure 4F), and the
Tyr
397-mutated FAK, overexpressed in COS7 cells, could
be co-immunoprecipitated with cortactin by the anti-cor-
tactin antibody (Figure 5J). Although cortactin could still
interact with the mutant FAK, the mutation disrupted the
interaction between FAK and Src, leading to a decrease in
cortactin phosphorylation. Tyrosine phosphorylation in
cortactin immunoprecipitated from COS7 cells overex-
pressing the mutant GFP-tagged FAK (Y397F) was drama-
tically reduced (Figure 5J). Thus, it appears that cortactin
tyrosine phosphorylation at focal adhesions requires the
formation of the FAK-Src complex.
To determine whether cortactin is phosphorylated by
FAK or by Src in the FAK-Src complex, cortactin tyro-
sine phosphorylation was analyzed in HEK293 cells
overexpressing GFP-tagged FAK, Src or both. The
results of this experiment suggest that cortactin was
phosphorylated by Src (Figure 6A). Furthermore, cortac-
tin tyrosine phosphorylation could be promoted by
expressing the constitutively active Src, but not the inac-
tive Src. And mutating the Src phosphorylation sites in
cortactin (Y421/466/475/482F) inhibited Src-catalyzed
cortactin tyrosine phosphorylation (Figure 6B).
The activation of Src in the FAK-Src complex was
designated by an increase in Tyr
418-phosphorylated Src
following cell adhesion (results not shown). Src was
recruited to focal adhesions by Tyr
397-autophosphory-
lated FAK to form the FAK-Src complex during cell
adhesion (Figure 6C). Although cortactin interacted with
FAK at focal adhesions, it was phosphorylated by Src
kinase in the FAK-Src complex. In cells overexpressing
active Src, most cortactin was phosphorylated and
recruited to cortical focal adhesions (Figure 6D and 6E).
In these cells, cortactin and its phosphorylated form
were well co-localized. In contrast, the expression of
inactive Src did not affect cortactin phosphorylation or
the formation of focal adhesions (Figure 6E).
Cell motility is regulated by FAK-Src complex-catalyzed
cortactin tyrosine phosphorylation
The FAK-Src complex holds the center stage in the reg-
ulation of cell motility [26]. Cell migration is inhibited
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Page 7 of 15Figure 5 Cell adhesion induced cortactin tyrosine phosphorylation requires FAK autophosphorylation at Tyr
397. (A) Adhesion induced
FAK and p130Cas tyrosine phosphorylation. 10, 30 and 120 min indicate the time elapsed after the HEK293 cells were plated onto fibronectin-
coated dishes. 0 min, suspended cells; Ad, cells cultured in dishes for 24 hours. a-FAK, a-pFAK, a-p130Cas and a-pp130 indicate western blots
with anti-FAK, anti-phosphotyrosine
397 FAK, anti-p130Cas and anti-phosphotyrosine
410 p130Cas antibodies, respectively (B) Adhesion-induced
cortactin tyrosine phosphorylation. Cortactin was immunoprecipitated (IP) from suspended HEK293 cells (0 min) and adhering cells (10, 30 and
120 min) with anti-cortactin antibody (a-Cttn). Cortactin tyrosine phosphorylation was detected with an anti-phosphotyrosine antibody (a-PY). (C)
Co-immunoprecipitation of cortactin and FAK. Cortactin was immunoprecipitated from adherent HEK293 cells with anti-cortactin antibody (a-
Cttn) or control IgG (IgG). The immunoprecipitated samples were analyzed by western blotting. (D) Immunofluorescence staining of FAK and
cortactin during cell adhesion. Actin was stained with phalloidin. Bar, 10 μm. (E) Immunofluorescence staining of Tyr
397-phosphorylated FAK and
Tyr
421-phosphorylated cortactin during cell adhesion. Bar, 10 μm. (F) FAK expression and autophosphorylation in cortactin knockdown cells.
Cortactin was knocked down by RNA interference in COS7 cells. Cortactin, FAK and Tyr
397-autophosphorylated FAK were detected by western
blotting. a-Tubulin was used as the loading control. (G) Cortactin expression and tyrosine phosphorylation in FAK knockdown cells. FAK was
knocked down by RNA interference in COS7 cells. siRNA, small interfering RNA; Luci, luciferase siRNA; FAK, FAK siRNA. FAK and cortactin proteins
were detected by western blotting. Cortactin was immunoprecipitated with anti-cortactin antibody (a-Cttn) and its tyrosine phosphorylation was
detected using an anti-phosphotyrosine antibody (a-PY). (H) Immunofluorescence staining of tyrosine phosphorylated cortactin in FAK
knockdown cells. FAK RNAi (FAK Ri) and control RNAi (Luci Ri) cells were stained for FAK (FAK) and Tyr
421-phosphorylated cortactin (pCttn). Bar, 50
μm. (I) Expression and phosphorylation of GFP-tagged FAK mutant (Y397F). The lysates of cells expressing GFP-tagged FAK or mutated FAK
(Y397F) were blotted with anti-EGFP (a-GFP), anti-FAK (a-FAK), anti-phosphotyrosine
397 FAK (a-pFAK) or anti-phosphotyrosine
576 FAK (a-pFAK
576)
antibodies. (J) Cortactin tyrosine phosphorylation in cells expressing the GFP-tagged FAK mutant (Y397F). Cortactin in cells expressing the GFP-
tagged or mutated (Y397F) FAK was immunoprecipitated with an anti-cortactin antibody and blotted with an anti-cortactin (a-Cttn), anti-
phosphotyrosine (a-PY) or anti-EGFP (a-GFP) antibody.
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Page 8 of 15in FAK-deficient cells and in cells treated with the Src
family kinase inhibitor, PP2 [32,33]. In HT1080 cells,
FAK knockdown by RNA interference inhibited cell
migration, as did inhibiting Src kinase activity with PP2
(Figure 7A, B and 7C). In addition, overexpressing the
GFP-tagged FAK mutant (Y397F), which prevents for-
mation of the FAK-Src complex, also inhibited cell
migration (Figure 7D). As a substrate of the FAK-Src
complex, cortactin was involved in regulating cell moti-
lity. Cortactin knockdown in HT1080 cells by RNA
interference inhibited cell migration (Figure 7A and 7E).
Cortactin interacted with FAK and was phosphory-
lated by the FAK-Src complex (Figures 4 and 6). To
investigate the role of FAK-Src complex-catalyzed cor-
tactin tyrosine phosphorylation in cell motility, the
phosphorylation sites in cortactin were mutated into
Phe residues (Y421/466/475/482F) to block tyrosine
phosphorylation. The Phe mutations in cortactin incom-
petent tyrosine phosphorylation by the FAK-Src com-
plex, but did not block the interaction of cortactin with
FAK (Figures 4D and 6B). Overexpressing the phosphor-
ylation-incompetent cortactin mutant (Y421/466/475/
Figure 6 Cortactin tyrosine phosphorylation by Src at focal adhesions. (A) Enhanced cortactin tyrosine phosphorylation in cells
overexpressing Src. Cortactin immunoprecipitated from HEK293 cells overexpressing GFP-tagged FAK, Src or both was blotted with an anti-
phosphotyrosine antibody. (B) Incompetent cortactin tyrosine phosphorylation by mutating Src phosphorylation sites. Myc-tagged cortactin C-
terminus (myc-CT) or mutated C-terminus (Y421/466/475/482F) [myc-CT(Y/F)] was co-expressed with GFP-tagged constitutively active Src (GFP-Src-
CA) or inactive Src (GFP-Src-IN) in HEK293 cells and immunoprecipitated with anti-myc antibody (a-myc). The tyrosine phosphorylation of myc-
tagged cortactin mutants was detected with anti-phosphotyrosine antibody (a-PY). (C) Activation of Src at focal adhesions during cell adhesion.
Bar, 10 μm. 10, 30 and 120 min indicate the time elapsed after the suspension of HEK293 cells were plated onto fibronectin-coated dishes. Cells
were stained with anti-FAK and anti-phosphotyrosine
418 Src antibodies. Actin was stained with phalloidin. (D) and (E) Immunofluorescence
staining of cortactin, Tyr
421 phosphorylated cortactin and paxillin in cells overexpressing GFP-tagged constitutively activated Src or inactive Src.
Bar, 50 μm. NIH3T3 cells expressing GFP-tagged constitutively activated Src (G-Src-CA) or inactive Src (G-Src-IN) were stained with anti-cortactin
(Cttn), anti-paxillin (Pax) and anti-phosphotyrosine
421 cortactin (pCttn) antibodies.
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Page 9 of 15482F) in HT1080 cells inhibited cell migration (Figure
8A and 8B), indicating that cortactin tyrosine phosphor-
ylation regulates cell migration.
The tyrosine phosphorylation of cortactin by the FAK-
Src complex most likely promotes its dissociation from
FAK because the interaction between the cortactin
phosphorylation mimic and FAK was greatly reduced
(Figure 4D). The phosphorylation-incompetent cortactin
mutant (Y421/466/475/482F) formed a stable interaction
with FAK, and cell migration was inhibited. In contrast,
the cortactin phosphorylation mimic exhibited increased
turnover at focal adhesions (Figure 4D) [34], greatly
enhancing cell migration (Figure 8A and 8B). Overex-
pressing wild-type cortactin in HT1080 cells led to an
Figure 7 Inhibition of cell migration by cortactin knockdown. (A) Cortactin and FAK knockdown by RNA interference. Ctrl, HT1080 cells; Luci,
luciferase siRNA control; Cttn, cortactin siRNA fragment; FAK, FAK siRNA fragment. Cortactin, FAK and a-tubulin were detected by western
blotting. (B) Inhibition of cell migration by FAK knockdown. Bar, 50 μm. The track depicts the positions of the cells taken at 3-min intervals. The
picture shows the cell at the starting point (0), at 180 min (180) and at 360 min (360 min). The plot is the results of 83 control RNAi cells (Luci)
and 81 FAK RNAi cells (Cttn). ***P < 0.001. (C) Inhibition of cell migration by PP2. Bar, 200 μm. Ctrl, normal medium; PP2, medium with 10 μM
PP2. Cell migration was determined by measuring the width of the gap at 4-minute intervals and normalized by the initial width of the gap. The
averaged results of six wound-healing gaps at 8-minute intervals are plotted. (D) Inhibition of cell migration by overexpressing the FAK mutant
(Y397F). Bar, 50 μm. GFP-tagged FAK or mutated FAK (Y397F) was expressed in HT1080 cells. The migration of the EGFP-positive cells was
tracked. The inserts are EGFP fluorescence pictures of cells taken at 360 min. 72 GFP-FAK cells and 57 GFP-FAK (Y397F) cells were plotted. ***P <
0.001. (E) Inhibition of cell migration by cortactin knockdown. The labels are the same as in panel B.
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Page 10 of 15increase in cellular cortactin, which might increase levels
of the phosphorylated form, thereby slightly enhancing
cell migration (Figure 8A and 8B). Taken together, these
results suggest that tyrosine phosphorylation of cortactin
regulates cell motility by increasing cortactin turnover at
focal adhesions.
Cortactin interacts with F-actin through its N-terminal
F-actin binding domains [10]. In order to understand
Figure 8 Inhibition of cell migration by blocking cortactin tyrosine phosphorylation.T r a c k so fl i v e - c e l lr e c o r d i n g s .B a r ,5 0μm. The
migration of HT1080 cells overexpressing EGFP (GFP), GFP-tagged cortactin (Cttn), the phosphorylation-incompetent cortactin mutant [Cttn(Y/F)],
the cortactin phosphorylation mimic mutant [Cttn(Y/E)] or their N-terminal truncated forms [CT, CT(Y/F), CT(Y/E)] were tracked. The inserts are
EGFP fluorescence picture of cells taken at 360 min. (B) Plot of migration speed. The numbers are the EGFP positive cells plotted. The statistical
analysis was made against the results of cells overexpressing EGFP. *P < 0.05; ***P < 0.001. (C) FAK and its autophosphorylation in cells
overexpressing N-terminal truncated cortactin mutants. FAK and its autophosphorylation at Tyr
397 in HT1080 cells overexpressing EGFP or GFP-
tagged cortactin C-terminus mutants were analyzed by western blotting. (D) Centrosome orientation in migrating cells expressing GFP-tagged
cortactin C-terminus mutants. HT1080 cells transfected with vector expressing GFP protein (EGFP), GFP-tagged cortactin C-terminus (GFP-CT),
phosphorylation-incompetent C-terminus (Y421/466/475/482F) [GFP-CT(Y/F)] or phosphorylation mimicking C-terminus (Y421/466/475/482E) [GFP-
CT(Y/E)] were subjected to wound-healing analysis. The centrosome (stained with anti-pericentrin antibody) in the GFP-positive cell at the
migration front was analyzed. Cells with centrosomes located within 120° of the migration direction were counted as polarized, and 200 cells
were plotted for each cortactin mutant.
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focal adhesions, the cortactin N-terminal domains were
truncated to disrupt its interaction with F-actin. With-
out these domains, the remaining cortactin C-terminus
could still interact with FAK and could be phosphory-
l a t e db yt h eF A K - S r cc o m p l e x( F i g u r e s4 Ca n d6 B ) .
However, cell migration was inhibited by overexpressing
the cortactin C-terminus in HT1080 cells (Figure 8A
and 8B). In addition, overexpressing the C-terminus of
the cortactin phosphorylation mimic also inhibited cell
migration (Figure 8A and 8B). Thus, the C-termini of
cortactin and the phosphorylation mimic interfere with
the ability of native cortactin to regulate cell migration.
The tyrosine phosphorylation of the cortactin C-termi-
nus was essential for its inhibitory effect on cell migra-
tion. Cell migration was not inhibited by the
phosphorylation-incompetent cortactin C-terminus (Fig-
ure 8A and 8B). The presence of the non-phosphory-
lated cortactin C-terminus did not affect the function of
phosphorylated cortactin. In summary, the increased
turnover of the cortactin phosphorylation mimic at focal
adhesions increased F-actin dynamics and promoted cell
migration. The stable association of the phosphoryla-
tion-incompetent cortactin at focal adhesions reduced
F-actin dynamics and inhibited cell migration. Truncat-
ing the N-terminal F-actin binding domains did not
affect F-actin dynamics. The stable association of the
phosphorylation-incompetent cortactin C-terminus at
focal adhesions appears to be independent of F-actin
dynamics and then had no effect on cell motility. How-
ever, the mechanism by which the C-terminus of the
cortactin phosphorylation mimic interferes with cellular
phosphorylated cortactin and inhibits cell migration
requires further study.
Discussion
At focal adhesions, Src and FAK form an active kinase
complex to phosphorylate associated proteins. The iden-
tification of cortactin, a Src kinase substrate and F-actin
associated protein [10], as a FAK interactor at focal
adhesions suggests that FAK-Src-catalyzed cortactin tyr-
osine phosphorylation is involved in the regulation of
cell motility (Figure 4). Src was the first oncogene to be
discovered and is one of the most intensely studied
[1-3]. In cancer cells, active Src not only increases cell
growth and survival, but also promotes actin cytoskele-
ton reorganization and decreases cell-cell and cell-
matrix adhesions to facilitate motility and invasiveness
[1,3]. Cortactin is frequently overexpressed in malignant
tumors and there is a correlation between cortactin
phosphorylation and enhanced cell migration and
metastasis [35,36]. Cortactin and its tyrosine phosphory-
lation are involved in adhesion-dependent cell edge pro-
trusion [37]. Cortactin is phosphorylated by Src at the
leading edge of lamellipodia, where in association with
the Arp2/3 complex, it initiates the branching of actin
filaments to promote the formation of membrane pro-
trusions [36,38]. The overexpression of constitutively
active Src appears to induce cortactin phosphorylation
and membrane protrusions at the edge (Figure 6D and
6E). Cell migration and invasion are essential elements
of cancer metastasis. During cancer cell invasion, cortac-
tin is one of the proteins that direct actin bundles to
form invadopodia [39]. The involvement of Src-cata-
lyzed cortactin phosphorylation in cell motility control
suggests cortactin might be a crucial regulator of cancer
metastasis.
For cell migration, the turnover of the cytoskeleton at
focal adhesions is more important than stable associa-
tion. To propel cell movement, the dynamic interplay
between the actin cytoskeleton and cell adhesion sites
induces membrane protrusions and generates traction
force. The external force exerted on the cell and the
internal force generated by the F-actin cytoskeleton dur-
ing cell migration are anchored and sensed at focal
adhesions, particularly by the FAK-Src complex [32,40].
O n em e t h o do fc e l lm o t i l i t yc o n t r o lb yt h eF A K - S r c
complex is the phosphorylation of FAK associated pro-
teins such as paxillin and p130Cas [40]. Mutating the
FAK-Src phosphorylation sites in paxillin (Tyr
31, 118)
inhibits the turnover of focal adhesions and reduces cell
motility [41]. Cortactin is phosphorylated by the FAK-
Src complex at C-terminal tyrosine residues (Tyr
421, 466,
475, 482; Figure 6) [8,9]. The structural configuration of
cortactin, which contains N-terminal F-actin binding
domains and C-terminal FAK association domains,
enables it to mediate the association between the F-
actin cytoskeleton and focal adhesions (Figure 4) [19].
By regulating the interaction between the cortactin C-
terminus and FAK, cortactin tyrosine phosphorylation is
able to control the association or dissociation of F-actin
at focal adhesions. This hypothesis is supported by the
results of the phosphorylation-incompetent cortactin
mutant (Y421/466/475/482F) and its N-terminal domain
truncated form. Blocking tyrosine phosphorylation by
mutating Tyr into Phe (Y421/466/475/482F) stabilizes
the interaction of cortactin with FAK, decreases the
turnover of F-actin at focal adhesions and inhibits cell
migration (Figure 4D and 8). By truncating the N-term-
inal F-actin binding domains, the remaining cortactin C-
terminus can no longer interact with F-actin. Its associa-
tion or dissociation at focal adhesions has no effect on
F-actin dynamics–the inhibitory effect on cell migration
by the stably-associated phosphorylation-incompetent
cortactin could be reversed by truncating the N-terminal
F-actin binding domains (Figure 8B).
The reduced interaction between the cortactin phos-
phorylation mimic and FAK suggests that cortactin
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lated (Figure 4D). Our results and those of others indi-
cate that the cortactin phosphorylation mimic promotes
focal adhesion turnover and increases cell migration
(Figure 8) [34]. It is very likely that cortactin tyrosine
phosphorylation by the FAK-Src complex dissociates
cortactin from focal adhesions and promotes F-actin
turnover. The inhibition of cell migration by the N-
terminal truncated cortactin phosphorylation mimic
implies additional functions for tyrosine phosphorylated
cortactin (Figure 8). Without the N-terminal F-actin
binding domains, the phosphorylation mimic C-terminal
can no longer interact with the F-actin cytoskeleton.
This suggests that the C-terminus of the cortactin phos-
phorylation mimic interferes with the ability of cortactin
to regulate motility. Importantly, the C-terminus of the
phosphorylation-incompetent cortactin mutant does not
have a similar inhibitory effect on cell migration (Figure
8). Thus, the effect of the cortactin phosphorylation
mimic C-terminus on cell migration is phosphorylation
specific. The wild-type cortactin C-terminus can also
inhibit cell migration because it can be phosphorylated
within the cell (Figure 6B and 8). It is not clear what
functions are perturbed by the cortactin phosphorylation
mimic C-terminus. FAK autophosphorylation and cen-
trosome orientation, which are important for cell moti-
lity control, are not affected by the cortactin C-terminal
mutants (Figure 8C and 8D). Further study is required
to clarify the role of the cortactin phosphorylation
mimic C-terminus on cell migration.
Conclusions
In summary, we demonstrate that cortactin is recruited
by FAK into focal adhesions, where it is phosphorylated
by the FAK-Src complex. The interaction between FAK
and cortactin is mediated by the SH3 domain and the
proline-rich region and is regulated by FAK-Src com-
plex-catalyzed cortactin tyrosine phosphorylation. Cor-
tactin at focal adhesions can further recruit cortactin
interacting proteins. The structure of cortactin, which
contains N-terminal F-actin binding domains and C-
terminal FAK association domains, allows it to function
as a bridge between the F-actin cytoskeleton and focal
adhesions. After the tyrosine phosphorylation of cortac-
tin by the FAK-Src complex, the reduced interaction of
cortactin with FAK leads to an increased turnover of the
associated F-actin at focal adhesions. These changes in
local F-actin dynamics ultimately regulate cell motility.
Methods
Materials
Anti-FAK, anti-phosphotyrosine
397 FAK, anti-Src, anti-
phosphotyrosine
418 Src, anti-p130Cas and anti-phospho-
tyrosine
410 p130Cas antibodies were purchased from Cell
Signaling (Danvers, MA, USA). Anti-phosphotyrosine
421
cortactin, anti-phosphotyrosine
466 cortactin, anti-a tubu-
lin and anti-myc tag primary antibodies were from Sigma
(St. Louis, MO, USA). DAPI, phalloidin, and horseradish
peroxidase-conjugated secondary antibodies were also
from Sigma. Anti-phosphotyrosine
482 cortactin antibody
was from Chemicon. Anti-cortactin, anti-phosphotyro-
sine and anti-EGFP antibodies were from Santa Cruz
Biotechnology (Santa Cruz, CA, USA). Anti-paxillin anti-
body was from Transduction Laboratories (San Jose, CA,
USA). The fluorescence secondary antibodies (Alexa
Fluor 488/546/647 conjugates) for immunofluorescence
were from Invitrogen (Carlsbad, CA, USA). PP2 was
from Calbiochem (San Diego, CA, USA). The Leica laser
scanning confocal microsystem, including the Leica TCS
SP2 confocal microscope, the Leica confocal scanner and
the Leica confocal acquisition software, was used with
the HCX PL APO 1bd. BL 63.0X/1.4 oil objective at 1.4
numerical aperture at a working temperature of 22°C.
The fluorescence medium was Sigma’s DABCO.
Cell culture, immunofluorescence staining,
immunoprecipitation and western blotting
COS7 cells, HEK293 cells, HT1080 cells and NIH3T3 cells
were cultured in Dulbecco’s modified Eagle’sm e d i u m
(DMEM) supplemented with 10% calf serum. For immuno-
fluorescence staining, cells cultured on glass coverslips
were fixed in 3.7% formaldehyde and 0.18% Triton X-100
in phosphate-buffered saline for 10 min. The fixed cells
were stained with primary and secondary antibodies [42].
The detailed characterization on the specificity of the phos-
pho-cortactin antibodies (anti-phosphotyrosine
421 cortactin
antibody, anti-phosphotyrosine
466 cortactin antibody and
anti-phosphotyrosine
482 cortactin antibody) is provided in
the supplementary data of our previous publication [23].
For immunoprecipitation, cells were lysed in 1% Triton X-
100 buffer containing 50 mM HEPES pH 7.4, 2.5 mM
EDTA, 150 mM NaCl, 30 mM b-glycerophosphate, 1 mM
sodium orthovanadate, 1 mM PMSF and 2 μl/ml protease
inhibitor cocktail. After centrifugation at 12 000 g for 15
min at 4°C to remove cell debris, the supernatant (500-
1000 μg protein) was mixed with 1.5 μg primary antibody
for immunoprecipitation [43]. For western blotting, the
sample in 1 × SDS sample buffer with 20 mM dithiothreitol
was heated at 100°C for 5 min, subjected to SDS-PAGE and
then transferred to an Immobilon-P membrane (Millipore,
Billerica, MA). Western blotting was conducted as pre-
viously described [43]. The target proteins were detected
using enhanced chemiluminescence.
Construction and expression of cortactin, FAK and Src
mutants and the analysis of their interactions
Murine cortactin cDNA, N-terminus (from aa 1 to 329),
C-terminus (from aa 330 to 546), phosphorylation-
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tion mimicking mutant (Y421/466/475/482E) and SH3-
domain deletion mutant (from aa 1 to 500) were con-
structed into GFP-tagged, myc-tagged or GST-tagged
expression vectors. Murine FAK cDNA, FERM (from aa
1t o4 0 0 ) ,ΔFERM (from aa 401 to 1052), ΔFRNK (from
aa 1 to 692), kinase domain (From aa 401 to 692),
FRNK (from aa 693 to 1052), FAT (from aa 919 to
1052), FRNK m1 [FRNK mutant 1 (P712/715A)], FRNK
m2 [FRNK mutant 2 (P876/879A)], FRNK m1/2 [FRNK
mutant (P712/715/876/879A)] and the autophosphoryla-
tion-incompetent mutant (Y397F) were constructed into
GFP-tagged expression vectors. The constitutively active
Src (Y527F) and the inactive Src (K295M) were con-
structed from chicken Src. These tagged fusion proteins
were expressed in cells by transient transfection follow-
ing the protocol for Invitrogen’s Lipofectamine 2000.
The experiments were carried out 48 hours after
transfection.
For co-immunoprecipitation, GFP-tagged fusion pro-
teins were expressed in COS7 cells and the cell lysates
were immunoprecipitated with anti-FAK antibody. For
GST pull-down assays, GST-tagged cortactin was
expressed in E. coli and isolated using glutathione-agar-
ose beads. The lysates of HEK293 cells expressing GFP-
tagged FAK mutants were incubated with GST-tagged
cortactin bound to glutathione-agarose beads. The pro-
teins were dissolved with 1 × SDS sample buffer and
detected by western blotting.
Cortactin tyrosine phosphorylation
HEK293 or HT1080 cells were resuspended in DMEM
with 0.5% bovine serum albumin and plated onto culture
dishes pretreated with 20 μg/ml fibronectin overnight
and 1% Bovine serum albumin for 1 hour (Millipore-pro-
tocol). The cells were harvested at 10, 30 and 120 min for
immunoprecipitation, immunofluorescence staining and
western blotting. Suspended cells were considered 0 min,
and normal cultured cells were adherent.
For RNA interference, COS7 cells were transfected
with FAK stealth siRNA (5’-GGUUCAAGCUG-
GAUUAUUUTT-3’), cortactin stealth siRNA (5’-AUCU-
CUCUGUGACUCGUGCUUCUCCTT-3’)o rL u c i f e r a s e
control siRNA (5’-CGUACGCGGAAUACUUCGATT-
3’) at a final concentration of 80 nM following the pro-
tocol provided by Invitrogen. For expression of fusion
proteins, COS7 and HEK293 cells were transfected with
vector expressing GFP-tagged or myc-tagged fusion pro-
teins. Forty-eight hours after transfection, cortactin tyro-
sine phosphorylation was analyzed.
Cell migration and statistical analysis
In HT1080 cells, RNA interference was used to knock
down cortactin or FAK. GFP-tagged proteins were
expressed by transient transfection. Forty-eight hours
after transfection, the cells were transferred onto plates
with a glass bottom for live-cell microscopic imaging and
cultured overnight. Cells were then transferred to Leibo-
vitz’s L15 medium with 10% FBS and mounted on a
Leica MDW live-cell imaging station with a 37°C heated
platform and a 20 × lens, and photographed every 3 min.
The images were processed with Image J software on
NIH Java and cells were tracked with Manual Tracking
in Image J software. The position of the nuclear center
for each cell was tracked, recorded and calculated for
average migration speed in a 6-hour period. Eight view-
fields were analyzed, and the cell numbers are indicated
in the figures. For cortactin and FAK RNAi experiments,
cells were randomly selected for analysis. For cells
expressing GFP-tagged fusion proteins, only GFP positive
cells were selected for analysis. Data are presented as
mean ± SD. Differences were analyzed using Student’st -
test. P < 0.05 was considered statistically significant.
The inhibition of cell migration by the Src family
kinase inhibitor, PP2 [33], was assessed with the wound-
healing assay. An HT1080 cell monolayer was scratched
with a rubber policeman, washed with phosphate-buffer
saline twice and fed with Leibovitz’s L15 medium with
10% FBS in the presence or absence of 10 μMP P 2 .T h e
cells were then mounted on the live-cell imaging station
on a 37°C heated platform and 10 × lens and photo-
graphed every 4 min.
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